These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 9433865

  • 21. Use of gastroprotection in patients discharged from hospital on nonsteroidal anti-inflammatory drugs.
    Coté GA, Norvell JP, Rice JP, Bulsiewicz WJ, Howden CW.
    Am J Ther; 2008; 15(5):444-9. PubMed ID: 18806520
    [Abstract] [Full Text] [Related]

  • 22. Is misoprostol cost-effective in the prevention of nonsteroidal anti-inflammatory drug-induced gastropathy in patients with chronic arthritis? A review of conflicting economic evaluations.
    Stucki G, Johannesson M, Liang MH.
    Arch Intern Med; 1994 Sep 26; 154(18):2020-5. PubMed ID: 8092907
    [Abstract] [Full Text] [Related]

  • 23. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study.
    Singh G, Ramey DR, Morfeld D, Shi H, Hatoum HT, Fries JF.
    Arch Intern Med; 1996 Jul 22; 156(14):1530-6. PubMed ID: 8687261
    [Abstract] [Full Text] [Related]

  • 24. Cost-conscious prescribing of nonsteroidal anti-inflammatory drugs for adults with arthritis. A review and suggestions.
    Greene JM, Winickoff RN.
    Arch Intern Med; 1992 Oct 22; 152(10):1995-2002. PubMed ID: 1417372
    [Abstract] [Full Text] [Related]

  • 25. Preventing non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: are older strategies more cost-effective in the general population?
    Elliott RA, Hooper L, Payne K, Brown TJ, Roberts C, Symmons D.
    Rheumatology (Oxford); 2006 May 22; 45(5):606-13. PubMed ID: 16368733
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL.
    Rheumatology (Oxford); 2003 Nov 22; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [Abstract] [Full Text] [Related]

  • 28. Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
    Maetzel A, Strand V, Tugwell P, Wells G, Bombardier C.
    Arthritis Rheum; 2002 Dec 15; 47(6):655-61. PubMed ID: 12522841
    [Abstract] [Full Text] [Related]

  • 29. Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies.
    Lanas A, Hunt R.
    Ann Med; 2006 Dec 15; 38(6):415-28. PubMed ID: 17008305
    [Abstract] [Full Text] [Related]

  • 30. Rates of serious gastrointestinal events from low dose use of acetylsalicylic acid, acetaminophen, and ibuprofen in patients with osteoarthritis and rheumatoid arthritis.
    Fries JF, Bruce B.
    J Rheumatol; 2003 Oct 15; 30(10):2226-33. PubMed ID: 14528521
    [Abstract] [Full Text] [Related]

  • 31. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents.
    Chan FK, Abraham NS, Scheiman JM, Laine L, First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents.
    Am J Gastroenterol; 2008 Nov 15; 103(11):2908-18. PubMed ID: 18853980
    [Abstract] [Full Text] [Related]

  • 32. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
    Salentijn GJ.
    Ned Tijdschr Geneeskd; 1999 Nov 13; 143(46):2340. PubMed ID: 10589227
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Economic effects of prophylactic use of misoprostol to prevent gastric ulcer in patients taking nonsteroidal anti-inflammatory drugs.
    Hillman AL, Bloom BS.
    Arch Intern Med; 1989 Sep 13; 149(9):2061-5. PubMed ID: 2505706
    [Abstract] [Full Text] [Related]

  • 35. Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population.
    Rahme E, Pettitt D, LeLorier J.
    Arthritis Rheum; 2002 Nov 13; 46(11):3046-54. PubMed ID: 12428249
    [Abstract] [Full Text] [Related]

  • 36. [Present position in the prevention and therapy of NSAID-induced ulcers].
    Lehmann FS, Beglinger C.
    Schweiz Med Wochenschr; 1999 Jul 27; 129(29-30):1073-80. PubMed ID: 10464910
    [Abstract] [Full Text] [Related]

  • 37. A novel composite endpoint to evaluate the gastrointestinal (GI) effects of nonsteroidal antiinflammatory drugs through the entire GI tract.
    Chan FK, Cryer B, Goldstein JL, Lanas A, Peura DA, Scheiman JM, Simon LS, Singh G, Stillman MJ, Wilcox CM, Berger MF, Breazna A, Dodge W.
    J Rheumatol; 2010 Jan 27; 37(1):167-74. PubMed ID: 19884267
    [Abstract] [Full Text] [Related]

  • 38. Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysis.
    El-Serag HB, Graham DY, Richardson P, Inadomi JM.
    Arch Intern Med; 2002 Oct 14; 162(18):2105-10. PubMed ID: 12374519
    [Abstract] [Full Text] [Related]

  • 39. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM.
    Best Pract Res Clin Gastroenterol; 2001 Oct 14; 15(5):755-73. PubMed ID: 11566039
    [Abstract] [Full Text] [Related]

  • 40. Economic evaluation of prophylactic treatment with Misoprostol in osteoarthritic patients treated with NSAIDs. The case of Belgium.
    Carrin GJ, Torfs KE.
    Rev Epidemiol Sante Publique; 1990 Oct 14; 38(3):187-99. PubMed ID: 2118670
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.